Aveanna Healthcare Holdings, Inc. AVAH

Healthcare SIC 8082 - Services-Home Health Care Services NAICS Health Care and Social Assistance › Ambulatory Health Care Services › Home Health Care Services derived Nasdaq

Aveanna is a Delaware corporation and was incorporated on November 30, 2016, originally under the name BCPE Oasis Holdings Inc. Aveanna commenced operations in March 2017 in connection with the transformative merger of Epic Health Services Inc. and Pediatric Services of America, Inc. in March 2017 under the name BCPE Eagle Holdings Inc. On May 26, 2017, we changed our name to Aveanna Healthcare Holdings Inc. and commenced trading on the Nasdaq Stock Market on April 29, 2021. Our principal executive offices are located at 400 Interstate North Parkway SE, Suite 1600, Atlanta, Georgia and our phone number is (770) 441-1580. We maintain a website at www.aveanna.com. Information contained on, or accessible through, our website is not a part of and is not incorporated by reference into this Annual Report on Form 10-K.

Last close 13.38 2026-10-23
Market cap $2.92B 2026-07-04 share count
52-week range 5.93 - 14.71

Valuation FY2025 figures against the last close

P/S1.2x
P/E12.7x
P/FCF23.2x
EV/EBITDA15.1x
Dividend yield—
Diluted EPS1.05

Where the revenue comes from as reported in the latest 10-K

Revenue by segment

  • PDS
  • HHH
  • MS
Revenue by segment, 3 categories over 2 years. The same figures are in the table below. FY2025 PDS, FY2025: 2B (82.2%) 82% PDS HHH, FY2025: 248.6M (10.2%) 10% HHH MS, FY2025: 183.5M (7.5%) 8% MS FY2024 PDS, FY2024: 1.6B (80.7%) 81% HHH, FY2024: 217.8M (10.8%) 11% MS, FY2024: 172.1M (8.5%) 9%
Segment FY2025FY2024
PDS $2.00B $1.63B
HHH $248.6M $217.8M
MS $183.5M $172.1M

As the company reported it, from the “Segment Information - Summary of Segment Information (Details)” note of its latest 10-K. Every figure here has been checked against the total revenue the same filing reported. Segments are the filer's own reporting structure, which is a decision about how it runs itself rather than a standard taxonomy: two companies in the same industry routinely divide themselves along different lines, so these are worth reading down a single company rather than across two. Slices under 1% are folded into “Other”.

Annual financial statements

Income statement

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Revenue $2.43B$2.02B$1.90B$1.79B$1.68B$1.50B$1.38B—
Gross profit $810.5M$635.5M$595.4M$553.2M$542.4M$454.5M$419.3M—
SG&A $374.5M$352.8M$361.0M$357.2M$297.4M$240.9M$227.8M—
Operating income $256.5M$139.8M$8.1M-$642.3M-$36.1M-$3.5M$39.0M—
Interest expense $140.1M$156.6M$153.2M$107.7M$68.9M$83.0M$92.3M—
Pre-tax income $106.9M$5.1M-$139.0M-$663.8M-$113.6M-$51.7M-$75.0M—
Income tax $118.1M$16.0M$4.5M$1.8M$3.5M$5.3M$1.5M—
Net income $225.0K-$10.9K-$134.5K-$662.0M-$117.0M-$57.0M-$76.5M—
EPS, basic 1.11-0.06-0.71-3.57-0.69———
EPS, diluted 1.05-0.06-0.71-3.57-0.69-0.40-0.56—
Shares, diluted (wtd. avg.) 215.0M192.9M190.0M185.6M170,625———

Balance sheet

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Cash and equivalents $193.3M$84.3M$43.9M$19.2M$30.5M$137.3M——
Receivables $313.4M$265.2M$236.6M$221.2M$218.9M$172.9M——
Total current assets $560.2M$392.7M$314.9M$269.8M$279.2M$340.6M——
Property, plant and equipment $16.7M$17.4M$20.5M$22.8M$31.4M$32.6M——
Goodwill $1.12B$1.05B$1.05B$1.16B$1.84B$1.32B$1.23B$1.23B
Other intangibles $92.6M$89.6M$94.0M$95.9M$102.9M$73.6M——
Total assets $2.01B$1.66B$1.61B$1.71B$2.33B$1.84B——
Short-term debt $13.2M$9.2M$9.2M$9.2M$8.6M$9.9M——
Total current liabilities $424.5M$402.2M$354.8M$326.5M$344.8M$260.4M——
Long-term debt $1.29B$1.27B$1.28B$1.28B$1.23B$1.16B——
Total liabilities $1.82B$1.79B$1.74B$1.72B$1.70B$1.58B——
Retained earnings -$1.16B-$1.38B-$1.37B-$1.24B-$574.7M-$457.6M——
Total equity $194.5M-$123.6M-$129.6M-$6.3M$635.8M$265.0M$270.2M$345.0M

Cash flow

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Operating cash flow $125.9M$32.6M$22.7M-$48.4M-$11.3M$116.6M-$8.7M—
Depreciation and amortisation $9.8M$9.6M$11.8M$15.2M$15.3M$13.0M$10.1M—
Stock-based compensation $25.1M$17.5M$13.2M$15.9M$14.4M$3.3M$1.9M—
Capital expenditure ————$15.9M$15.2M$16.6M—
Investing cash flow -$22.3M-$6.3M-$8.8M-$25.3M-$681.8M-$193.5M-$17.8M—
Financing cash flow $5.4M$14.0M$10.8M$62.4M$586.3M$210.9M$21.9M—

Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001193125-26-161632.

Plot the figures US dollars

Income statement Revenue Cost of revenue Gross profit R&D SG&A Total operating expenses Operating income Interest expense Pre-tax income Income tax Net income EPS, basic EPS, diluted Shares, diluted (wtd. avg.)
Balance sheet Cash and equivalents Short-term investments Receivables Inventory Total current assets Property, plant and equipment Goodwill Other intangibles Total assets Accounts payable Short-term debt Total current liabilities Long-term debt Total liabilities Retained earnings Total equity
Cash flow Operating cash flow Depreciation and amortisation Stock-based compensation Capital expenditure Investing cash flow Financing cash flow Dividends paid Buybacks
  • Revenue
  • Gross profit
  • Net income
Revenue, Gross profit, Net income by fiscal year, in US dollars The same figures are in the table below this chart. -1B 0 1B 2B 3B Revenue, FY2019: 1.4B Gross profit, FY2019: 419.3M Net income, FY2019: -76.5M Revenue, FY2020: 1.5B Gross profit, FY2020: 454.5M Net income, FY2020: -57M Revenue, FY2021: 1.7B Gross profit, FY2021: 542.4M Net income, FY2021: -117M Revenue, FY2022: 1.8B Gross profit, FY2022: 553.2M Net income, FY2022: -662M Revenue, FY2023: 1.9B Gross profit, FY2023: 595.4M Net income, FY2023: -134.5K Revenue, FY2024: 2B Gross profit, FY2024: 635.5M Net income, FY2024: -10.9K Revenue, FY2025: 2.4B Gross profit, FY2025: 810.5M Net income, FY2025: 225K FY2018 FY2019 FY2020 FY2021 FY2022 FY2023 FY2024 FY2025
Fiscal year FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue — $1.38B $1.50B $1.68B $1.79B $1.90B $2.02B $2.43B
Gross profit — $419.3M $454.5M $542.4M $553.2M $595.4M $635.5M $810.5M
Net income — -$76.5M -$57.0M -$117.0M -$662.0M -$134.5K -$10.9K $225.0K

Recent filings and events

  • Other event The catch-all. The company chose to disclose something that fits no other item, so the content is whatever it says it is. Item 8.01
  • Results announced The quarterly or annual earnings release. Arrives four times a year from almost every company here. Item 2.02
  • Regulation FD disclosure Something the company told the market and had to tell everyone at once - usually a slide deck or a press release. Item 7.01
  • Regulation FD disclosure Item 7.01
  • Officer or director change Someone at the top arrived or left. The item covers everything from a board retirement to a chief executive being removed, and only the filing itself says which. Item 5.02
  • Other event Item 8.01
  • Shareholder vote The results of the annual meeting or a special vote. Item 5.07
  • Other event Item 8.01
  • Regulation FD disclosure Item 7.01
  • Results announced Item 2.02
  • Regulation FD disclosure Item 7.01
  • Regulation FD disclosure Item 7.01

Item numbers are Form 8-K's own, and a filing date is up to four business days after the thing it reports. The same feed across the whole market.

Others in SIC 8082

TickerCompanyMarket capP/ERevenue growth
BTSG BrightSpring Health Services, Inc. $11.89B 69.1x 28.2%
CHE CHEMED CORP $6.70B 28.0x 4.1%
OPCH Option Care Health, Inc. $4.90B 24.6x 13.0%
ADUS Addus HomeCare Corp $2.27B 23.3x 23.2%
AHCO AdaptHealth Corp. $820.8M — -0.5%